Endovastec(SH:688016) Sou Hu Cai Jing·2025-10-12 19:31Core Viewpoint - The company, Xinmai Medical, announced a cash dividend distribution and adjusted its share repurchase plan following the distribution, reflecting its ongoing commitment to returning value to shareholders [1][2][3]. Trading Information Summary - As of October 10, 2025, Xinmai Medical's stock closed at 110.58 yuan, down 1.9%, with a turnover rate of 1.27% and a trading volume of 15,600 shares, amounting to a total transaction value of 174 million yuan [1]. - On the same day, the net inflow of main funds was 7.95 million yuan, accounting for 4.56% of the total transaction value, while retail investors experienced a net outflow of 4.23 million yuan, representing 2.43% of the total transaction value [1][3]. Company Announcement Summary - Xinmai Medical announced a cash dividend of 1.3 yuan per share (tax included), with the record date set for October 16, 2025, and the ex-dividend date on October 17, 2025. The total cash dividend distribution amounts to approximately 157.19 million yuan (tax included) based on the adjusted share count [1][2]. - Following the dividend distribution, the upper limit for the second phase of the share repurchase plan was adjusted from 178.01 yuan per share to 176.73 yuan per share, effective from October 17, 2025. The total repurchase amount is set between 100 million yuan and 200 million yuan [2][4]. - As of September 30, 2025, the company had repurchased a total of 1,263,043 shares, representing 1.02% of the total share capital, with a cumulative repurchase amount of approximately 133 million yuan [3][4].